Our study’s findings on the higher proportion of males in the G6PD deficiency patients’ group and in the G6PD with COVID-19 patients’ group are consistent with previous research showing a higher prevalence of G6PD deficiency among males than females [28,29]. This evidence concerns the gene G6PD and G6PD deficiency.